The Narayana Hrudalaya share price has had a dream run in 2025. The stock is up over 20% in 2025 and even if we check the stock price over 1-year time frame, it has delivered almost similar returns to investors. Positive views from brokerages and string business fundamentals have helped enhance the stock’s appeal. Here are three reasons driving the positive sentiment in the share value –
Kotak Institutional Equities on Narayana Hrudayalaya: Steady growth in India business
The brokerage firm, Kotak Institutional Equities, has reiterated its ‘ADD’ rating on Narayana Hrudayalaya, with a price target of Rs 1,490 per share. This implies an upside of 4% from current levels. According to the brokerage, Narayana Hrudayalaya reported a strong performance in Q3FY25, driven by strong traction in its Cayman operations and steady growth in its India business.
“Aided by a further improvement in mix and higher occupancies in new hospitals, we bake in 12%/16% India sales/EBITDA CAGRs over FY2024-27E. We now expect a faster ramp-up in the new Camana Bay hospital and bake in a healthy 16% overall EBITDA CAGR over FY2024-27E,” added the brokerage in its report.
Kotak Institutional on Narayana Hrudayalaya: Cayman expansion gains momentum
One of the key highlights of Narayana Hrudayalaya’s Q3 results noted down in the brokerage report was the performance of its Cayman Islands unit, particularly the newly opened Camana Bay facility.
According to the brokerage report, the Cayman business posted a 14% YoY revenue growth in Q3, with a 21% sequential increase (QoQ). EBITDA margins have also improved, resulting in analysts to revise their expectations for a faster ramp-up at Camana Bay.
ALSO READStock Market Live Today: Markets in the red, Nifty struggling around 22,000, Sensex down nearly 400 points
“We now bake in a faster ramp-up of this hospital,” the report notes, indicating that EBITDA breakeven could be achieved sooner than the company’s previous guidance of 4-5 quarters.
With lower than expected operational costs and strong initial demand, the brokerage now forecasts 17% revenue CAGR and 15% EBITDA CAGR for the Cayman business over FY24-27.
Kotak Institutional on Narayana Hrudayalaya: Growth in billing rates, expansion
In India, according to the brokerage house, Narayana Hrudayalaya continued to show strong performance with 13% YoY revenue growth, reaching Rs 10.7 billion in Q3. The growth was driven by a 9% YoY rise in Average Revenue Per Occupied Bed (ARPOB).
» Read More
